Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma

Completed · Phase 2

Conditions studied: Leukemia, Lymphoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of two treatment regimens for patients in developing countries with diffuse non-Hodgkin's lymphoma and acute lymphoblastic leukemia.

Key facts

Study ID

NCT00018954

Run by

National Institutes of Health Clinical Center (CC)

Starts

1992-10-01

Expected to finish

2002-10-01

Last updated by the study team

2012-02-20

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support — Bethesda, Maryland, United States
• National Cancer Institute of Egypt — Cairo, Egypt
• Kidwai Memorial Institute of Oncology — Bangalore, India
• Cancer Institute (W.I.A.) — Madras, India
• Tata Memorial Centre — Mumbai, India

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.